Edition:
United Kingdom

Invacare Corp (IVC.N)

IVC.N on New York Stock Exchange

19.20USD
22 Jun 2018
Change (% chg)

$-0.20 (-1.03%)
Prev Close
$19.40
Open
$19.45
Day's High
$19.50
Day's Low
$19.10
Volume
137,438
Avg. Vol
69,878
52-wk High
$19.95
52-wk Low
$12.32

Chart for

About

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company's geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific. The Company... (more)

Overall

Beta: 2.41
Market Cap(Mil.): $484.84
Shares Outstanding(Mil.): 33.96
Dividend: 0.01
Yield (%): 0.34

Financials

  IVC.N Industry Sector
P/E (TTM): -- 32.19 32.74
EPS (TTM): -1.93 -- --
ROI: -8.12 13.89 14.38
ROE: -14.02 16.72 16.08

BRIEF-Invacare Reports Q1 Adjusted Loss Per Share $0.35

* Q1 EARNINGS PER SHARE VIEW $-0.38 -- THOMSON REUTERS I/B/E/S

07 May 2018

BRIEF-Invacare Corp Says CEO Matthew Monaghan's 2017 Total Pay Was $8.2 Mln Vs $4.1 Mln In 2016 – SEC Filing

* INVACARE CORP SAYS CEO MATTHEW E. MONAGHAN'S 2017 TOTAL COMPENSATION WAS $8.2 MILLION VERSUS $4.1 MILLION IN 2016 – SEC FILING Source text: (https://bit.ly/2JtAzCW) Further company coverage:

09 Apr 2018

BRIEF-Invacare Says 2020 Goals Include Commitment To Achieve $100 Mln Of Annual Run-Rate EBITDA

* INVACARE - 2020 GOALS INCLUDE COMMITMENT TO ACHIEVE $100 MLN OF ANNUAL RUN-RATE EBITDA - SEC FILING Source text: (https://bit.ly/2Hlewxy) Further company coverage:

09 Apr 2018

BRIEF-Invacare Appoints Kathleen Leneghan CFO

* INVACARE APPOINTS KATHLEEN LENEGHAN CHIEF FINANCIAL OFFICER

22 Feb 2018

BRIEF-Invacare Corp Transfers Küschall Wheelchair Production From Switzerland To France

* INVACARE CORPORATION TRANSFERS KÜSCHALL WHEELCHAIR PRODUCTION FROM SWITZERLAND TO FRANCE

12 Feb 2018

BRIEF-Invacare Corp Reports Q4 Loss Per Share $0.54

* ORATION ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR ENDED DECEMBER 31, 2017

07 Feb 2018

BRIEF-Invacare Says On Jan 3, FDA Notified Co That Its Unit Alber GMBH's Responses To Warning Letter Diclosed In Sept 2017 Are "Adequate" - SEC Filing

* INVACARE SAYS ON JAN 3, FDA NOTIFIED CO THAT ITS UNIT ALBER GMBH'S RESPONSES TO WARNING LETTER DICLOSED IN SEPT 2017 ARE "ADEQUATE" - SEC FILING

05 Jan 2018

Earnings vs. Estimates